Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. 31 gru 2022 · In contemporary practice, percutaneous closure of the patent ductus arteriosus (PDA) has become the procedure of choice. While the surgical ligation of ductus arteriosus ensures an immediate and definitive obliteration of the ductus, this therapeutic option is rarely used and reserved for situations when percutaneous solution is unsuitable.

  2. Patent ductus arteriosus (PDA) occurs in over 50% of neonates below 28 weeks gestational age. 1 Most clinicians prefer to treat PDA, although some have argued treatment is not necessary. 2–4 The hemodynamic consequences of PDA involve the following: excess pulmonary circulation resulting in an increased risk for respiratory failure, pulmonary ed...

  3. Overview. Background. Patent ductus arteriosus (PDA) is a persistent communication between the descending thoracic aorta and the pulmonary artery that results from failure of normal...

  4. 28 kwi 2021 · Patent ductus arteriosus (PDA) is a congenital heart disease that, if left untreated, can lead to pulmonary hypertension, congestive heart failure, and death. Here, we aimed to assess postoperative cardiac hemodynamic changes and surgical techniques, as well as early and late postoperative findings in surgically treated PDA patients.

  5. 25 sty 2023 · During a catheter procedure, the health care provider inserts a thin tube into a blood vessel in the groin and guides it to the heart. A plug or coil passes through the catheter. The plug or coil closes the ductus arteriosus. The treatment doesn't usually require an overnight hospital stay.

  6. Patent ductus arteriosus (PDA) is one of the most common congenital heart diseases (CHD) as it accounts for 10–16% of CHDs [1,2]. Since 1967, when Porstmann conducted the first transcatheter closure to treat PDA [ 3 ], scientists have enhanced the device and delivery systems that physicians use when performing transcatheter closures tremendously.

  7. 3 wrz 2022 · Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev . 2013;2013:CD003951. Crossref

  1. Ludzie szukają również